GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology
Proceeds to support commercialization of GenomicsNext™ – a first-of-its-kind liquid biopsy platform bringing fast, reliable gene expression quantitation to cell-free DNA blood samples to provide deeper insight beyond DNA mutations DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics, a…